Mirum Pharmaceuticals, Inc.
MIRM
$71.97
$0.160.22%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 60.07% | 38.31% | -67.12% | 42.22% | 2.54% |
| Total Depreciation and Amortization | 0.07% | -18.33% | 22.38% | 3.43% | 3.35% |
| Total Amortization of Deferred Charges | -1.39% | 4.09% | -1.89% | 4.18% | -1.69% |
| Total Other Non-Cash Items | 2.54% | 39.35% | 49.63% | -35.39% | 24.26% |
| Change in Net Operating Assets | 41.97% | -571.64% | -150.45% | 113.31% | -93.47% |
| Cash from Operations | 713.97% | 61.31% | -227.21% | 204.76% | -125.00% |
| Capital Expenditure | -207.32% | -105.00% | 88.95% | 76.77% | -5,892.31% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 59.78% | -2,534.64% | 103.70% | 75.18% | -- |
| Cash from Investing | 59.10% | -2,617.00% | 103.55% | 75.20% | -559,261.54% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 36.63% | 19.08% | 38.23% | -47.02% | 505.06% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 36.63% | 19.08% | 38.23% | -47.02% | 505.06% |
| Foreign Exchange rate Adjustments | 111.00% | 176.50% | -1,667.05% | 173.95% | -205.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 253.12% | -2,192.06% | 95.39% | 85.43% | -519.86% |